The CD28/HLA-DR expressions on CD4+ T but not CD8+ T cells are significant predictors for progression to AIDS

被引:20
作者
Choi, BS
Park, YK
Lee, JS
机构
[1] Korea Univ, Natl Inst Hlth, Ctr AIDS Res, Dept Virol, Seoul 122701, South Korea
[2] Korea Univ, Grad Sch Biotechnol, Seoul 122701, South Korea
关键词
HIV; CD4; level; HLA-DR molecule; CD28; molecule; disease progression;
D O I
10.1046/j.1365-2249.2002.01732.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the changes of CD28 and HLA-DR molecules on CD4(+) and CD8(+) T cells during HIV infection, we classified 130 HIV-infected Koreans into four groups by the CD4 level as follows: group I (greater than or equal to500 cells/mm(3) ), group II (201-499 cells/mm(3) ), group III (51-200 cells/mm(3) ), and group IV (less than or equal to50 cells/mm(3) ). In CD4(+) T cells, the proportion of CD28 expression decreased significantly with the CD4 level while the proportion of HLA-DR expression increased gradually. In particular, the changes of HLA-DR expressions on CD4(+) T cells were parallel to the loss of CD28 molecules from stage III to IV. However, the CD28 expression on CD8(+) T cells decreased dramatically in the early stage of HIV infection, and the sum and pattern of CD28 and HLA-DR expressions on CD8(+) T cells was stable after the first stage. Even though CD28 down-regulation on CD8(+) T cells was very severe from the early stage of HIV infection, it might not influence the survival time of HIV-infected Koreans. The sum of the CD28(+) subsets and HLA-DR subsets in each T cell was stable in all stages of disease progression. The sums of the CD28(+) subsets and HLA-DR+ subsets in CD4(+) T and CD8(+) T cells were constant as approximately 100% and 55-60% of each T cell. These results suggested that the changes of CD28/HLA-DR expressions on CD4(+) T cells were more predictable than those on CD8(+) T cells in the evaluation of the disease progression during HIV-infected periods. However, we need further studies to understand why the sum of two molecules in each T cell are constant.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 46 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]   PROGNOSTIC FACTORS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS WITH A CD4(+) LYMPHOCYTE COUNT LESS-THAN-50/MU-L [J].
APOLONIO, EG ;
HOOVER, DR ;
HE, YH ;
SAAH, AJ ;
LYTER, DW ;
DETELS, R ;
KASLOW, RA ;
PHAIR, JP .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :829-836
[3]   Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy [J].
Behbahani, H ;
Landay, A ;
Patterson, BK ;
Jones, P ;
Pottage, J ;
Agnoli, M ;
Andersson, J ;
Spetz, AL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) :150-156
[4]   Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities [J].
Bisset, LR ;
Cone, RW ;
Huber, W ;
Battegay, M ;
Vernazza, PL ;
Weber, R ;
Grob, PJ ;
Opravil, M .
AIDS, 1998, 12 (16) :2115-2123
[5]   LYMPHOCYTE-ACTIVATION IN HIV-1 INFECTION .2. FUNCTIONAL DEFECTS OF CD28- T-CELLS [J].
BORTHWICK, NJ ;
BOFILL, M ;
GOMBERT, WM ;
AKBAR, AN ;
MEDINA, E ;
SAGAWA, K ;
LIPMAN, MC ;
JOHNSON, MA ;
JANOSSY, G .
AIDS, 1994, 8 (04) :431-441
[6]   EXPRESSION OF COSTIMULATORY MOLECULE CD28 ON T-CELLS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - FUNCTIONAL AND CLINICAL CORRELATIONS [J].
BRINCHMANN, JE ;
DOBLOUG, JH ;
HEGER, BH ;
HAAHEIM, LL ;
SANNES, M ;
EGELAND, T .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :730-738
[7]  
Bürgisser P, 1999, CLIN EXP IMMUNOL, V115, P458
[8]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[9]  
*CDC, 1993, MMWR-MORBID MORTAL W, V41, pRR1
[10]   Enhancement of bovine growth hormone gene expression by increasing the plasmid copy number [J].
Choi, JW ;
Ra, KS ;
Lee, YS .
BIOTECHNOLOGY LETTERS, 1999, 21 (01) :1-5